• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pre-Stroke Loop Diuretics and Anemia in Elderly Patients Are Associated Factors of Severe Renal Dysfunction at the Time of Acute Stroke Onset.老年患者卒中前使用袢利尿剂和贫血是急性卒中发作时严重肾功能不全的相关因素。
J Cardiovasc Dev Dis. 2023 Sep 19;10(9):405. doi: 10.3390/jcdd10090405.
2
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
3
Potential adverse effects of a low-dose aspirin-diuretic combination on kidney function.低剂量阿司匹林与利尿剂联合使用对肾功能的潜在不良影响。
Int J Clin Pharmacol Ther. 2007 Nov;45(11):601-5. doi: 10.5414/cpp45601.
4
Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.根据 Cockcroft-Gault、肾脏病饮食改良试验-4 和慢性肾脏病流行病学协作公式估计肾小球滤过率的差异以及与急性冠状动脉综合征患者结局的关系。
J Am Heart Assoc. 2018 Apr 21;7(9):e008725. doi: 10.1161/JAHA.118.008725.
5
Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?肌酐清除率、Cockcroft-Gault公式与胱抑素C:老年人真实肾小球滤过率的估算指标?
Gerontology. 2002 May-Jun;48(3):140-6. doi: 10.1159/000052832.
6
Enhanced Renal Clearance in Patients With Hemorrhagic Stroke.出血性脑卒中患者的肾脏清除能力增强。
Crit Care Med. 2019 Jun;47(6):800-808. doi: 10.1097/CCM.0000000000003716.
7
Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.肾病饮食改良法与Cockcroft-Gault方程在抗菌药物给药剂量计算方面的比较。
Pharmacotherapy. 2009 Jun;29(6):649-55. doi: 10.1592/phco.29.6.649.
8
Chronic kidney disease staging in nursing home and community older adults: does the choice of cockcroft-gault, modification of diet in renal disease study, or the chronic kidney disease epidemiology collaboration initiative equations matter?养老院和社区老年人群慢性肾脏病分期:选择 Cockcroft-Gault、肾脏病饮食改良研究(MDRD)公式还是慢性肾脏病流行病学协作倡议(CKD-EPI)公式重要吗?
J Am Med Dir Assoc. 2012 Feb;13(2):151-5. doi: 10.1016/j.jamda.2010.11.003. Epub 2010 Dec 22.
9
Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.使用血管紧张素转换酶抑制剂和糖皮质激素治疗的动脉高血压是系统性硬化症中与肾小球滤过率降低相关的独立危险因素。
Rheumatol Int. 2017 Mar;37(3):363-368. doi: 10.1007/s00296-016-3632-y. Epub 2016 Dec 22.
10
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.老年人肾功能、骨密度、骨质流失和骨质疏松性骨折的测量:兰乔贝纳多研究
J Bone Miner Res. 2007 Feb;22(2):203-10. doi: 10.1359/jbmr.061014.

引用本文的文献

1
Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study.达格列净对急性心力衰竭患者再入院和袢利尿剂使用的影响:一项回顾性倾向评分匹配队列研究。
BMC Cardiovasc Disord. 2024 Aug 2;24(1):402. doi: 10.1186/s12872-024-04078-5.

本文引用的文献

1
N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis.N-/T型与L型钙通道阻滞剂治疗慢性肾脏病的系统评价与Meta分析
Pharmaceuticals (Basel). 2023 Feb 22;16(3):338. doi: 10.3390/ph16030338.
2
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
3
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.达格列净治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
4
Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review.终末期肾病维持性透析患者的抗血小板治疗:最新综述。
Cardiovasc Drugs Ther. 2023 Oct;37(5):975-987. doi: 10.1007/s10557-022-07366-4. Epub 2022 Jul 22.
5
Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease.直接口服抗凝药物在晚期和终末期肾病患者中的安全性和疗效。
Int J Environ Res Public Health. 2022 Jan 27;19(3):1436. doi: 10.3390/ijerph19031436.
6
Prevalence, recognition and management of chronic kidney disease in Japan: population-based estimate using a healthcare database with routine health checkup data.日本慢性肾脏病的患病率、识别与管理:基于包含常规健康检查数据的医疗数据库的人群估计
Clin Kidney J. 2021 Jan 24;14(10):2197-2202. doi: 10.1093/ckj/sfab016. eCollection 2021 Oct.
7
Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.运用生理学模型质疑 L 型钙通道阻滞剂在慢性肾病中的肾保护作用。
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F548-F557. doi: 10.1152/ajprenal.00233.2021. Epub 2021 Sep 6.
8
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
9
Sodium Restriction Counseling Reduces Cardiac Events in Patients With Heart Failure.钠限制咨询可减少心力衰竭患者的心脏事件。
Circ J. 2021 Aug 25;85(9):1555-1562. doi: 10.1253/circj.CJ-20-1215. Epub 2021 Jun 22.
10
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病:病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.

老年患者卒中前使用袢利尿剂和贫血是急性卒中发作时严重肾功能不全的相关因素。

Pre-Stroke Loop Diuretics and Anemia in Elderly Patients Are Associated Factors of Severe Renal Dysfunction at the Time of Acute Stroke Onset.

作者信息

Mori Takahisa, Yano Tetsundo, Yoshioka Kazuhiro, Miyazaki Yuichi

机构信息

Department of Stroke Treatment, Shonan Kamakura General Hospital, Kamakura City 247-8533, Japan.

出版信息

J Cardiovasc Dev Dis. 2023 Sep 19;10(9):405. doi: 10.3390/jcdd10090405.

DOI:10.3390/jcdd10090405
PMID:37754834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10532343/
Abstract

BACKGROUND

Severe renal dysfunction (SRD), an advanced stage of chronic kidney disease (CKD), can limit the treatment options for acute stroke (AS) patients. Therefore, it is important to investigate the associated factors of SRD in AS patients to inhibit CKD progression to SRD before AS. Sex differences exist in the renal function. Therefore, we investigated the frequency of SRD and its associated factors among AS patients by sex.

METHODS

Our cross-sectional study included patients admitted within 24 h of AS onset between 2013 and 2019 with available pre-stroke medication information. We used the Cockcroft-Gault equation for calculating the creatinine clearance (Ccr) and defined SRD as a Ccr < 30 mL/min. We performed multivariable logistic regression analysis to identify the independent factors associated with SRD.

RESULTS

Out of 4294 patients, 3472 matched our criteria. Of these, 1905 (54.9%) were male, with median ages of 75 and 81 years for males and females, respectively. The frequency of SRD was 9.7% in males and 18.7% in females. Loop diuretics and anemia were associated factors of SRD.

CONCLUSIONS

Pre-stroke loop diuretics and anemia in elderly patients were associated factors of SRD in both sexes. Individualized drug therapy and anemia management are essential to prevent SRD.

摘要

背景

严重肾功能不全(SRD)是慢性肾脏病(CKD)的晚期阶段,会限制急性卒中(AS)患者的治疗选择。因此,研究AS患者中SRD的相关因素,以在AS发生前抑制CKD进展为SRD很重要。肾功能存在性别差异。因此,我们按性别调查了AS患者中SRD的发生率及其相关因素。

方法

我们的横断面研究纳入了2013年至2019年间AS发病24小时内入院且有卒中前用药信息的患者。我们使用Cockcroft-Gault方程计算肌酐清除率(Ccr),并将SRD定义为Ccr < 30 mL/分钟。我们进行多变量逻辑回归分析以确定与SRD相关的独立因素。

结果

4294例患者中,3472例符合我们的标准。其中,1905例(54.9%)为男性,男性和女性的中位年龄分别为75岁和81岁。男性SRD的发生率为9.7%,女性为18.7%。袢利尿剂和贫血是SRD的相关因素。

结论

老年患者卒中前使用袢利尿剂和贫血是两性SRD的相关因素。个体化药物治疗和贫血管理对于预防SRD至关重要。